Vitamin C is an essential nutrient, well known for its use in preventing scurvy and treating autoimmune illnesses and infections. Vitamin C has a long and controversial history with respect to its potential use as an anti-cancer agent. At present, vitamin C is classified as a complementary/alternative treatment for cancer. Recently, in vitro and animal studies discovered that high dose intravenous vitamin C acts as a pro-drug, selectively killing cancer cells. This literature review aims to analyse the latest research into the effectiveness of high dose intravenous vitamin C in the treatment of cancer.
High dose intravenous vitamin C in the management of cancer – a literature review
Please Share This Share this content
- Opens in a new window Twitter
- Opens in a new window Facebook
- Opens in a new window Google+
- Opens in a new window Pinterest
- Opens in a new window LinkedIn
- Opens in a new window Viber
- Opens in a new window VK
- Opens in a new window Reddit
- Opens in a new window Tumblr
- Opens in a new window Viadeo
- Opens in a new window WhatsApp